Literature DB >> 11835398

Phytoestrogen genistein stimulates the production of osteoprotegerin by human trabecular osteoblasts.

Volker Viereck1, Carsten Gründker, Sabine Blaschke, Heide Siggelkow, Günter Emons, Lorenz C Hofbauer.   

Abstract

The anti-resorptive effects of estrogen on bone metabolism are thought to be mediated through modulation of paracrine factors produced by osteoblastic lineage cells that act on osteoclastic lineage cells. Receptor activator of nuclear factor-kappaB ligand (RANKL) is the essential factor for osteoclast formation and activation and enhances bone resorption. By contrast, osteoprotegerin (OPG), which is produced by osteoblastic lineage cells acts as a decoy receptor that neutralizes RANKL and prevents bone loss. Recently, 17 beta-estradiol was found to stimulate OPG mRNA levels and protein secretion in a human osteoblastic cell line through activation of the estrogen receptor (ER)-alpha. In this study, we assessed the effects of the phytoestrogen genistein on OPG mRNA steady state levels (by semiquantitative RT-PCR and Northern analysis) and protein production (by ELISA) in primary human trabecular osteoblasts (hOB) obtained from healthy donors. Genistein increased OPG mRNA levels and protein secretion by hOB cells by up to two- to six-fold in a dose- (P<0.0001) and time-dependent (P<0.0001) fashion with a maximum effect at 10(-7) M. Co-treatment with the pure ER antagonist ICI 182,780 completely abrogated the stimulatory effects of genistein on OPG protein secretion, indicating that these effects were specific and directly mediated through the ER. Pre-treatment with genistein partially prevented the inhibitory effects of the glucocorticoid dexamethasone on OPG mRNA and protein production. The stimulation of OPG mRNA levels by genistein was not affected by the protein synthesis inhibitor, cycloheximide and was shown to be due to enhancement of OPG gene transcription. In conclusion, our data suggest that the phytoestrogen genistein is capable of upregulating the production of OPG by human osteoblasts. Thus, dietary sources of phytoestrogens may help to prevent bone resorption and bone loss by enhanced osteoblastic production of OPG. Copyright 2002 Wiley‐Liss, Inc.anti‐resorptive effects of estr

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11835398     DOI: 10.1002/jcb.10087

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  10 in total

1.  Five-year follow-up study of a kidney-tonifying herbal Fufang for prevention of postmenopausal osteoporosis and fragility fractures.

Authors:  Wei-Min Deng; Peng Zhang; Hai Huang; You-Gao Shen; Qin-Hua Yang; Wei-Li Cui; Yang-Shu He; Song Wei; Zhu Ye; Fang Liu; Ling Qin
Journal:  J Bone Miner Metab       Date:  2012-06-22       Impact factor: 2.626

2.  Genistein, a phytoestrogen, improves total cholesterol, and Synergy, a prebiotic, improves calcium utilization, but there were no synergistic effects.

Authors:  LeeCole L Legette; Wang-Hee Lee; Berdine R Martin; Jon A Story; Ali Arabshahi; Stephen Barnes; Connie M Weaver
Journal:  Menopause       Date:  2011-08       Impact factor: 2.953

3.  Dose-dependent effects of genistein on bone homeostasis in rats' mandibular subchondral bone.

Authors:  Yong-qi Li; Xiang-hui Xing; Hui Wang; Xi-li Weng; Shi-bin Yu; Guang-ying Dong
Journal:  Acta Pharmacol Sin       Date:  2011-11-28       Impact factor: 6.150

4.  In vitro and in vivo effects of puerarin on promotion of osteoblast bone formation.

Authors:  Ming-Yu Zhang; Hui Qiang; Hua-Qing Yang; Xiao-Qian Dang; Kun-Zheng Wang
Journal:  Chin J Integr Med       Date:  2012-03-30       Impact factor: 1.978

5.  Neither antioxidants nor genistein inhibit the progression of established atherosclerotic lesions in older apoE deficient mice.

Authors:  Michelle M Averill; Brian J Bennett; Marcello Rattazzi; Rebecca M Rodmyre; Elizabeth A Kirk; Stephen M Schwartz; Michael E Rosenfeld
Journal:  Atherosclerosis       Date:  2008-07-01       Impact factor: 5.162

6.  Isoflavones with supplemental calcium provide greater protection against the loss of bone mass and strength after ovariectomy compared to isoflavones alone.

Authors:  Pearl L Breitman; Debbie Fonseca; Angela M Cheung; Wendy E Ward
Journal:  Bone       Date:  2003-10       Impact factor: 4.398

7.  Soymilk or progesterone for prevention of bone loss--a 2 year randomized, placebo-controlled trial.

Authors:  Eva Lydeking-Olsen; Jens-Erik Beck-Jensen; Kenneth D R Setchell; Trine Holm-Jensen
Journal:  Eur J Nutr       Date:  2004-04-14       Impact factor: 5.614

8.  Labisia pumila regulates bone-related genes expressions in postmenopausal osteoporosis model.

Authors:  Siti Noor Fathilah; Norazlina Mohamed; Norliza Muhammad; Isa Naina Mohamed; Ima Nirwana Soelaiman; Ahmad Nazrun Shuid
Journal:  BMC Complement Altern Med       Date:  2013-09-05       Impact factor: 3.659

Review 9.  Molecular signaling mechanisms behind polyphenol-induced bone anabolism.

Authors:  Elisa Torre
Journal:  Phytochem Rev       Date:  2017-08-31       Impact factor: 5.374

10.  Therapeutic and Preventive Effects of Osteoclastogenesis Inhibitory Factor on Osteolysis, Proliferation of Mammary Tumor Cell and Induction of Cancer Stem Cells in the Bone Microenvironment.

Authors:  Mitsuru Futakuchi; Takao Nitanda; Saeko Ando; Harutoshi Matsumoto; Eri Yoshimoto; Katsumi Fukamachi; Masumi Suzui
Journal:  Int J Mol Sci       Date:  2018-03-16       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.